SCHEMBL5268317

SCHEMBL5268317

CN(C)[S+]([O-])N(CC(=O)O)Cc1cccc(OCCc2coc(-c3ccccc3)n2)c1

nearest known ligand 0.57

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 20/20 0.57
PPARG P37231 16/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5226562 0.91 FFAR1 (0.51) PPARAPPARG
SCHEMBL5229490 0.86 PPARA (0.50) PPARAPPARG
SCHEMBL5229267 0.82 PPARA (0.58) PPARAPPARG
SCHEMBL4389591 0.80 PPARA (0.55) PPARAPPARG
SCHEMBL7156371 0.76 PPARA (0.50) PPARAPPARG
SCHEMBL4748568 0.76 KDR (0.53) PPARAPPARG
SCHEMBL5229270 0.76 PPARA (0.51) PPARAPPARG
SCHEMBL4391056 0.76 PPARA (0.56) PPARAPPARG
SCHEMBL4393196 0.76 PPARA (0.51) PPARAPPARG
SCHEMBL5230667 0.76 PPARA (0.50) PPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778654-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME Crystalgenomics, Inc. (KR) 2007-05-02 EP claimed
WO-2006006832-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME CRYSTALGENOMICS, INC. (KR) 2006-01-19 WO claimed